CalmiGo

ShcA proteins: new targets for age-related diseases?

Latest articles

The Sheekey Science Show – Aging Clocks

Aging clocks - how to measure biological age. I hope you have some time on you hands as today we will talk all about aging...

Berberine could be longevity’s “best-kept secret”

From tackling senescence to lowering blood sugar, berberine is the supplement with a host of tricks up its sleeves. Berberine is a bioactive compound found...

Over a third of Generation X have multiple health problems

More than one in three British adults are suffering from two or more chronic health conditions in middle age, such as recurrent back problems,...

Forget the arms race – it’s time for a longevity race

Professor Andrew Scott outlines how society needs to change in order to capitalise on multi-trillion dollar longevity dividend. Last week, we brought you the views...

Most read

New NAD+ boosting longevity supplement hits the market

Elevant Prime dietary supplement contains a “high purity” form of NMN that has completed safety and toxicology testing. New York based health and wellness brand...

David Sinclair to co-chair $200 million biotech SPAC

Christian Angermayer's Frontier Acquisition Corp. holds significant longevity interest with David Sinclair and Peter Attia as Co-Chairs of the Board. Frontier Acquisition Corporation, a special...

Tree of Longevity – understanding how supplements work

Pathways? Hallmarks? Biomarkers? Understanding the longevity supplements lingo can help you make better choices for your healthspan. Longevity supplements differ from other 'generic supplements' as...
Seno

Editor's picks

The Sheekey Science Show – Aging Clocks

Aging clocks - how to measure biological age. I hope you have some time on you hands as today we will talk all about aging...

Berberine could be longevity’s “best-kept secret”

From tackling senescence to lowering blood sugar, berberine is the supplement with a host of tricks up its sleeves. Berberine is a bioactive compound found...

Over a third of Generation X have multiple health problems

More than one in three British adults are suffering from two or more chronic health conditions in middle age, such as recurrent back problems,...
CalmiGo

Click the globe for translations.

Evidence suggests that ShcA proteins may accelerate aging – targeting them could reduce age-related diseases.

Src homology and collagen A (ShcA) proteins are a family of adapter proteins regulating various physiological processes, including cell growth, cell migration metabolism. However, their role in aging has remained largely unknown – until now. Recent evidence suggests that ShcA proteins may play a critical role in aging and regulate the onset of age-related diseases [1].

Longevity.Technology: The ShcA protein family consists of three protein variants: p46Shc, p52Shc and p66Shc. In response to external stimuli, ShcA proteins activate various signalling cascades, enabling cells to respond to different signals. Although all three ShcA proteins contain domains mediating their interaction with lipids and other proteins, the cellular responses initiated by the different ShcA variants are extremely diverse [2].

In contrast to p46Shc and p52Shc, p66Shc contains a CH2 domain, making p66Shc’s structure unique. Intriguingly, p66Shc has multifaceted roles in cell growth, inducing both cell proliferation and cell death. This dual functionality of p66Shc in cell growth is largely attributed to the additional CH2 domain and its unique structure [2].

In a recent review article published in the journal Ageing Research Reviews, Hilal Ahmad Mir et al. highlight that p66Shc may represent a reliable diagnostic and prognostic biomarker for chronic age-related disorders. The authors note that in addition to regulating cell growth and cell migration, p66Shc also regulates the production of reactive oxygen species (ROS), thereby orchestrating cellular responses to oxidative stress. [2].

Under oxidative stress conditions, p66Shc promotes mitochondrial dysfunction and enhances ROS production, exacerbating oxidative stress and increasing the risk for neurodegenerative and metabolic age-related diseases [2, 3]. In mice, p66Shc depletion extended lifespan by 30% and protected animals from acute ischemia and brain aging. Additionally, low p66Shc expression levels have been associated with a decreased risk of diabetes and other metabolic disorders [2, 4].

Moreover, alterations in p66Shc expression promote tumour progression by enhancing cancer cell metastasis and inducing STAT3-driven immune suppression. Therefore, the authors highlight that the p66Shc/ROS pathway may represent a promising target for the treatment of cancer, neurodegeneration, metabolic disorders and other chronic age-related diseases [2].

Despite increasing evidence implicating the p66Shc/ROS pathway in many age-related pathologies, p66shc inhibition may cause undesirable effects owing to the paradoxical roles of p66Shc in cell growth and apoptosis. Hence, further in-depth structural and functional studies are required to fully uncover the role of the p66Shc/ROS pathway in health and disease and develop interventions that specifically inhibit certain functions of p66Shc while maintaining others.

[1] https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5624076/
[2] https://www.sciencedirect.com/science/article/pii/S1568163720302749
[3] https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3454471/
[4] https://bit.ly/2SSmxAC

Image by OpenClipart-Vectors from Pixabay

Christos Evangelou
Since the completion of his undergraduate and doctoral studies in Molecular Biosciences, Christos has been working in the medical communications industry, driven by his passion for communicating sciences. Apart from helping researchers to publish their studies, Christos writes articles related to sciences and medicine.
CalmiGo

Most popular

New NAD+ boosting longevity supplement hits the market

Elevant Prime dietary supplement contains a “high purity” form of NMN that has completed safety and toxicology testing. New York based health and wellness brand...

David Sinclair to co-chair $200 million biotech SPAC

Christian Angermayer's Frontier Acquisition Corp. holds significant longevity interest with David Sinclair and Peter Attia as Co-Chairs of the Board. Frontier Acquisition Corporation, a special...

Tree of Longevity – understanding how supplements work

Pathways? Hallmarks? Biomarkers? Understanding the longevity supplements lingo can help you make better choices for your healthspan. Longevity supplements differ from other 'generic supplements' as...

Spermidine: the mind-enhancing supplement

Scientists are finding that a high intake of dietary spermidine could slow down (or reverse) the brain aging process. Memory loss and slower brain function...
Seno

Related articles

Taxi cab drivers aid dementia research in brain trial

UCL aims to help drive the fight against dementia by enlisting London's Black Cab drivers in a unique brain testing trial. London’s black cab drivers, famed...

Increased pace of aging in COVID-related mortality

Deep Longevity releases an AI-based predictor of COVID time-to-death. Deep Longevity, which is spearheading the provision of deep biomarkers of aging, has announced the publication...

A pawsitive take in Alzheimer’s disease modelling

As purr-plexing as it may seem, cats may provide key answers in the study of dementia and Alzheimer’s disease. As we get older, our brain...

Reader Poll: just what does your future look like?

Your future is getting inexorably nearer – but will that be in high-tech comfort in your own home, down the road in a state-of-the-art...

Gerostate passes crowdfunding goal for antiaging drug platform

Longevitytech.fund joins investment round as Buck Institute start-up continues crowdfunding campaign to move antiaging drug candidates into mammalian studies. With around two weeks still remaining...
Seno